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African American (AA) men have the highest incidence of prostate cancer (PCa) 
compared to their White and Hispanic counterparts and a higher mortality rate than any 
other ethnicity. While biological and socioeconomic factors are to be blamed, many AA 
men are not aware of the opportunities for screening or the prognoses for the condition. 
There is an obvious need for increased awareness in AA men concerning preventative 
screening for PCa. Following the Walden University Clinical Practice Guideline Manual 
and guided by the Appraisal of Guidelines for Research & Evaluation (AGREE II) model 
to guide and validate the newly developed clinical practice patient education guideline 
(CPPEG), an evidence-based CPPEG was developed from an in-depth review of peer-
reviewed literature and validated to address PCa screening in AA men. The PCa CPPEG 
was scored by a panel of four content experts using the AGREE II instrument. Domain 
scores ranged from 92% for Domain 6, editorial independence, to 100% for Domain 1, 
scope and purpose, with all scores greater than the 75% benchmark indicating that no 
revisions were needed, and a 96% agreement rate indicating that the expert panel agreed 
that the PCa CPPEG should be used in the clinical setting, fulfilling the purpose and 
answering the practice-focused questions. This project will bring about positive social 
change through educating AA men about PCa screening and early treatment to increase 
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This project is dedicated to my father, Eric Austin, who passed away August 16, 
2019, from prostate cancer. I would also like to dedicate this to my mother, Hortense 
Austin, who passed away from cancer. Dad, you got the opportunity to see me halfway 
through my journey; I wish my mother had gotten the opportunity to see me, but I know 
she is in heaven smiling down. To my children, Sherika and Romando, thank you for 
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Section 1: Nature of the Project  
The prevalence of prostate cancer (PCa) is disproportionately high in African 
American (AA) men when compared to other ethnic groups in the United States. The 
reasons for such disparity are still unclear, but factors to which the prevalence is 
attributed include nutrition, race, family history, and lack of screening (Shenoy et al., 
2016). Screening as a preventive measure is recommended early and regularly to ensure 
that early detection leads to effective treatment and recovery (Tsodikov et al., 2017); 
however, the stigma surrounding PCa in the AA community, the body part that is 
affected, the related embarrassment, and fear of the procedure cause barriers to 
receptiveness to being screened.  
Wardle et al. (2015) explained that targeting clinicians with education was an 
effective means to optimize screening among individuals at risk for cancer. Similarly, 
Saei Ghare Naz et al. (2018), in a systematic review, found that patient-based education 
was among the most effective methods in modifying cervical cancer screening behavior 
of women. Educational programs geared toward practitioners were identified as effective 
in increasing patients’ awareness of the risks for PCa and the benefits of routine 
screening (Rice et al., 2017). Programs designed to educate AAs about the need for PCa 
screening have the potential to increase their awareness and compliance. Through 
developing an evidence-based clinical practice patient education guideline (CPPEG) 
related to PCa screening practices in AA men, I have provided a tool to better prepare 
practitioners to educate the population with ethnically sensitive information. Nurses 




educate AA men to make informed decisions in their care. Becoming more aware of the 
benefits of PCa screening should increase knowledge and screening rates; increased 
screening for PCa in AA men should produce a positive cultural transformation, ideally 
leading to a decrease in the disparity by leading to earlier diagnosis and treatment, quality 
care, and improved health outcomes and quality of life.  
Problem Statement 
PCa is the second leading cause of male deaths in the United States (Siegel et al., 
2020); the American Cancer Society (ACS, 2019) estimated that more than 202,000 men 
have PCa, of which over 73,000 are expected to die from the disease. According to the 
ACS (2016), Florida ranks second among all states in the United States for estimated new 
cases of PCa and second in estimated deaths from the disease. In Florida, AA men 
continue to face disparities in diagnosis, mortality rates, and access to cancer treatment. 
According to Healthy People 2020, AA men in Florida were the only group that did not 
meet the objective of reducing the death rate among the population from 21.2 per 100,000 
men. Among males diagnosed with PCa in the United States, AA men are over-
represented, with AA men twice as likely to be diagnosed and die from PCa as their non-
Hispanic White counterparts (Shenoy et al., 2016). In 2019, an estimated 30,000 cases of 
PCa were diagnosed in AA men, accounting for 30% of all cancers diagnosed in this 
group. The lifetime risk of diagnosing PCa is 15.9%, while the lifetime risk of death is 
2.8%. PCa incidence is 60% higher in AA men than in Whites. Furthermore, mortality is 
double in AA men compared to Whites. AA men are collectively observed to have the 




States compared to all other population groups. The high incidence of PCa in AAs has, 
for more than 20 years, remained remarkably constant (Tsodivoc et al., 2017).  
Through this CPPEG project, I have developed a tool that all practitioners can use 
to educate AA men with the intention of increasing PCa screening among this vulnerable 
group. The ACS (2020) has published guidelines that recommend that men begin 
screening for PCa at age 50 years; however, AAs and others with a high risk should begin 
at age 45. The screening involves checking prostate-specific antigen (PSA) levels and 
having a digital rectal exam (DRE) routinely. All men need to be educated on how to 
recognize the signs of PCa, what a DRE is, what a prostate biopsy entails and when it 
would be recommended, and interpretation of the PSA results (ACS, 2020). AA men 
need education tailored to them because they have potential cultural, socioeconomic, and 
healthcare access barriers (Cobran et al., 2018) that could cause reluctance to be 
screened. Hahn et al. (2015) found that members of the AA population, in many 
situations, only become aware of PCa when a close friend or relative is affected by the 
disease. Many men are not aware of the interlink between race and the prevalence of PCa 
or even the interlink between age and the onset of PCa. Another fact that many AA men 
are not aware of is the possibility of PCa being asymptomatic.  
Because of AA men’s vulnerability and reluctance to be screened, education is 
needed to address common barriers, including stigma, the body part that is affected, 
related embarrassment, and fear of the procedure (Shenoy et al., 2016).  
Dickey et al. (2017) supported this need in a study that focused on AA men over the age 




the disease. The study findings revealed that participants who received education showed 
increased participation in screening tests by approximately 21.4%. Another study by 
Ukoli et al. (2013), also studying PCa education and screening among AA men, showed 
that education interventions increased knowledge about PCa among AA men; screening 
test rates rose from 49% to 71%. For high-quality patient education tailored toward the 
targeted community, AAs, culturally sensitive, evidence-based guidelines should be 
available. The lack of evidence-based, culturally sensitive education materials was a gap 
in practice that I addressed by developing the CPPEG. Culturally sensitive education has 
the potential to increase AAs’ participation in getting screened and decreasing mortality 
from PCa (Ukoli et al., 2013). Although providers may be aware of new PCa screening 
guidelines, they may lack the knowledge or tools to educate AA men facing screening 
decisions about how best to proceed. Through this project, I have brought awareness of 
the need for culturally sensitive patient education as well as provided a culturally 
sensitive education tool related to AAs and PCa.  
Purpose Statement 
Practitioners are at the forefront of efforts to promote healthy behaviors, and there 
is a lack of evidence-based teaching guidelines to assist practitioners in educating AA 
men about PCa screening (Hoffman, 2020). AA males lack awareness of the importance 
of or need for PCa screening, despite the availability of such screening. Many AA males 
have negative attitudes toward annual routine checkups and limited knowledge and 
skewed perceptions of PCa screening (Hahn et al., 2015). Hence, the practice-focused 




from the literature supports the need for patient education related to PCa screening in AA 
men? Can a CPPEG be developed and validated to guide nurses in educating AA men on 
the importance of PCa screening? My goal was to provide a culturally sensitive guideline 
for all practitioners with relevant information needed to prepare AA men to make 
informed decisions about PCa screening with the potential to increase compliance with 
screening and early treatment. AA men are at a higher risk of developing and dying from 
PCa due to disparities in biological factors such as tumor biology; environmental factors 
such as exposure to cancer-causing pollutants; and lifestyle factors such as social stress, 
diet, body weight, physical activity, and smoking (Mucci et al., 2019). For this 
demographic, the literature lacks clarity and specificity regarding how one should 
structure an educational plan at the provider level to meet the AA male’s unique needs. 
Hence, there was a need for this Doctor of Nursing Practice (DNP) CPPEG project, PCa 
in AA Men, designed to increase providers’ knowledge of how to increase knowledge 
about PCa screening among AA men, with the hope of increasing screening and 
decreasing death rates.  
Education has been shown to be effective in changing individuals’ attitudes 
regarding their lifestyles and health practices (Hahn et al., 2015). For example, following 
education campaigns, mammogram screening increased from 31% to 56% (Tataro et al., 
2020); cervical cancer screening improved in five African states (Ebu et al., 2019); and 
education was found to be successful in increasing cancer screening among Korean 
American men (Peterson et al., 2018). AA men are often reluctant to visit doctors, or they 




attention for early detection of PCa; thus, culturally sensitive educational materials are 
needed. This CPPEG addressed the need for comprehensive, culturally based education 
guidelines for providers to share with AA men to change their perceptions. 
Nature of the Doctoral Project 
Evidence for the PCa in AA Men project was obtained from an exhaustive 
literature search that I continued until the newly developed CPPEG was revised and 
approved by an expert panel, which included a nurse practitioner, an oncologist, an 
oncology nurse with her MSN, and a primary care nurse practitioner. The Walden 
University library databases EBSCO host, ProQuest Direct, Cumulative Index to Nursing 
and Allied Health Literature (CINAHL), Google Scholar, PubMed, and Medline Plus, 
along with Open Library and SpringerLink, were used to find up-to-date, peer-reviewed 
articles related to PCa and AAs’ beliefs and responses. Search terms that I used included 
PCa, AA, disparities, and educational guidelines for PCa teaching. I ensured relevancy to 
the topic of AA and PCa by reviewing abstracts. This in-depth search for literature 
related to AA men and PCa provided me with the most current evidence on the state of 
the research and how best to address the gap that was the focus for this project.  
Approach  
The Walden University Clinical Practice Guideline Manual and the Appraisal of 
Guidelines for Research and Evaluation (AGREE) II tool (AGREE Enterprise, n.d.) 
were the primary guides for addressing the procedural steps of this PCa in AA Men 
project. Articles selected to help address the gap of AAs not going for PCa screening 




within the last 5 years unless they were landmark studies, and organized in a literature 
matrix. I graded the evidence using the Fineout-Overholt (2011) grading system (see 
Appendix B). The AGREE II tool (AGREE Enterprise, n.d.) was used to guide the 
development and evaluation of the CPPEG. The AGREE II tool is a valid and reliable 
framework that is used to evaluate the veracity and quality of newly developed 
guidelines.  
In line with the Clinical Practice Guideline Manual, I developed my practice-
focused questions and determined my evidence selection criteria. I developed an 
evidence-based CPPEG based on the literature discovered in the in-depth literature 
search. An expert panel of four members was identified to include a nurse practitioner, 
an oncologist, an oncology nurse with her MSN, and a primary care nurse practitioner to 
evaluate the newly developed CPPEG. Revisions of the guidelines were made based on 
the recommendations of the expert panel until consensus was reached. Next, a group of 
key stakeholders (practitioners who care for AA males) was identified and asked to 
review the newly developed CPPEG for content and usability. I developed a final report 
and shared it with the expert panel and stakeholders. After I graduate and the restrictions 
of the pandemic are lifted, I will present the guidelines to related practices in the area 
and present at local, regional, and national venues to share the tool for widespread use. 
According to Owens et al. (2019), there is a need to identify some of the most effective 
methods of promoting PCa awareness among AA men.  
The purpose of this DNP project, PCa in AA men, was to develop a CPPEG to 




importance of PCa screening with an ethnically appropriate teaching tool. Providers are 
often the first access point for health care in the United States; it is imperative to 
comprehend what mechanisms may underlie the differences between AAs and other 
populations and what can be done to narrow the gap (Tsodikov, 2017). Early screening 
for PCa is an effective method of decreasing mortality and morbidity, in that a 5% 
increase in the rate of screening PCa can avert about 500 related deaths per year 
(Tsodikov, 2017). 
Significance 
This CPPEG will impact several stakeholders and organizations, including 
hospitals, nurses, and patients. Addressing PCa among AA men will benefit the 
community’s health and improve the livelihood of its members. The main positive impact 
that this project will have on an organization level is financial stability from increased 
reimbursement related to better patient outcomes. A nurse’s role in PCa awareness, 
prevention, diagnosis, and treatment is essential. Nurses will be impacted by increased 
job satisfaction due to the significant impact that they will have in helping AAs make 
informed decisions in their care. The American Nurses Association (2018) noted a 25% 
increase in nurse job satisfaction over a 2-year span linked with an overall quality of care 
increase between 5% and 20% due to educating patients in making informed decisions. 
Nurses will also have the tools necessary to educate AA men to more effectively dispel 
many myths related to prostate screening. 
Patients will be affected by having increased knowledge about the benefits of 




and improve their quality of life. According to Reynolds (2008), educational programs 
associated with PCa will benefit patients by dispelling misconceptions, with medical 
practitioners playing an important role in the process. The aim of this DNP PCa in AA 
Men project was to provide resources to all providers involved in the care of AA men so 
that they would be better equipped to educate these men to raise awareness of the prostate 
screening process, leading to early diagnosis, intervention, and improved patient 
outcomes, thus lessening disparity and decreasing mortality and morbidity among the 
population. 
This newly developed CPPEG is transferable to multiple practice areas such as 
doctors’ offices, clinics, and all healthcare settings where AA men are treated, as the 
myths and mistrust are global (Shenoy et al., 2016). The end product of the project 
provides an educational approach for practitioners that is culturally appropriate and 
tailored to AA men to address the unique needs for this group related to PCa. This 
CPPEG will need to be tailored to apply the guideline to any other population or disease 
process, addressing the specifics of the disease process and ethnic needs of the target 
group. While the importance of PCa screening is universal, the AA population has unique 
fears and beliefs to be addressed to improve their screening rates and decrease the 
disparity that this vulnerable group faces with regard to PCa. AA men have higher 
mortality rates from PCa than any other ethnicity (Shenoy et al., 2016).  
The positive social change that a CPPEG to address PCa in AA men will bring 
about is an increase in knowledge related to PCa screening, which should eventually lead 




mirroring Walden University’s mission to improve human conditions through educational 
resources. The integrated theory of behavior change (Ryan, 2009) indicates that health 
behavior change can be improved by promoting knowledge and beliefs, increasing self-
regulation skills and abilities, and enhancing social facilitation. According to Hoffman 
(2020), early PCa screening has benefits of reducing the effects of the disease, especially 
for men who are at risk for advanced stages of PCa. Some men are motivated to be 
screened when they learn that early detection of PCa can improve their survival and 
prevent some of the life changes that will impede a full, healthy life (James et al., 2017).   
Summary 
This section well defined the problem statement that AA men lack awareness of 
the importance of or need for PCa screening despite the availability of such screening. 
Subsequently, my project approach was to develop a CPPEG as a guide for providers to 
educate AA men on screening methods and the importance of attaining screening. My 
purpose statement exposed the gap in practice for this project, which was the lack of 
educational resources for AA men about the benefits of PCa screening. This project is 
anticipated to have a positive impact on the target population by providing enhanced 
teaching resources for providers and improved health outcomes for AA men. In Section 
2, I will discuss the context of the project, the model selected to guide this project, and 




Section 2: Background and Context 
PCa is reported to be the second highest cause of male deaths in the United States 
(Siegel et al., 2020), with AAs disproportionately affected relative to other ethnic groups 
and twice as likely to die from the disease (Shenoy et al., 2016). Screening is crucial to 
detect PCa at an early stage to optimize treatment and recovery (Tsodikov et al., 2017). 
Therefore, the practice-focused questions for this project were as follows: What evidence 
from the literature supports the need for patient education related to PCa screening in AA 
men? and Can a CPPEG be developed and validated for PCa screening in AA men to 
effectively increase screening rates? Through this DNP PCa in AA men project, my 
purpose was to develop an evidence-based CPPEG to guide clinicians when educating 
AA men about the methods and importance of PCa screening. In this section, I will 
describe the AGREE II model that was used to guide this project, as well as address the 
relevance of the project to nursing practice and my role as a DNP student in the 
development of this project. 
Models 
The AGREE II tool was used to guide and validate the newly developed CPPEG. 
The AGREE II instrument is currently the most applied and comprehensively validated 
guideline appraisal tool worldwide (Brouwers et al., 2010) and is a standard guide that 
can be applied to guidelines in any disease area targeting any step in the health care 
continuum, including those for health promotion, public health, screening, diagnosis, 




used to guide the development of evidence-based practice guidelines as well as future 
research in clinical practice recommendations (Shallwani et al., 2019). 
Hoffmann-Eßer et al. (2018) reported that the main quality domains that the tool 
addresses include the scope and purpose of the teaching, stakeholders’ involvement, and 
the rigor of development for those involved. Other priority domains in the process are 
clarity in presentation, applicability, and editorial independence. The AGREE II model 
has been used in various studies, including Shallwani et al.’s (2019) assessment of the 
strengths of and needed improvements to current guidelines being implemented for 
physical activity or exercise recommendations for people with cancer. Wang et al. (2019) 
recommended using the AGREE II tool to make improvements and strengthen specific 
guidelines for nonvariceal upper gastrointestinal bleeding.  
Relevance to Nursing Practice 
PCa is the second leading cause of death in men in the United States, with PCa 
incidence in AA men around 60% higher and death rates 2 or 3 times higher than in 
Caucasian men (Shenoy et al., 2016). Shenoy et al. (2016) reported a 90% 5-year survival 
rate for PCa if a prostate tumor is detected early, compared to only 35% for more 
advanced disease stages. Black men comprise a high-risk group for PCa whose members 
may profit from precautionary screening for early detection of PCa. 
The ACS (2020) has published guidelines that recommend that men at age 50 
begin screening for PCa, but AAs and others in high-risk groups should begin screening 
at age 45; according to He and Mullins (2017), screening at as early as 40 years of age 




detection, the better chance of survival for the patient (Tsodikov et al., 2017). There is no 
definitive explanation for the disparity in PCa between AAs and non-Hispanic Whites; 
however, He and Mullins (2017) hypothesized that a genetic difference, a clinical 
difference in the course of the disease, social barriers, and poor access to healthcare were 
responsible. Furthermore, Cobran et al. (2018), in their study of AA and Caribbean men, 
found other reasons for not visiting doctors, such as family history, lack of health 
insurance, misconceptions about how prostate screening is done, and misinformation 
from healthcare providers about when to screen. Advanced metastatic PCa occurs at a 
ratio of 4:1 in AA men and White men, respectively (Shenoy et al., 2016). The disease 
transforms early from an indolent to aggressive state in Black men. The need to address 
PCa among AA men is more obvious with the expanding rate among AA men despite the 
registered decline in White men’s mortality rates (Cobran et al., 2018). 
The differences in the disease course and differences in social issues that 
disproportionately affect AA men place a greater health burden on these patients than the 
rest of the population; hence, early diagnosis may improve overall health outcomes. The 
U.S Preventive Services Task Force needs to adequately take into consideration 
racial/ethnic differences when issuing screening guidelines (Shenoy et al., 2016). 
Establishing separate screening guidelines for men of AA ancestry would help facilitate 
earlier diagnosis and reduce mortality from the disease. Rice et al. (2017) studied the 
impact of educational interventions on the risk of PCa with AA men between the ages of 




disease and increase their participation in screening. Educational interventions must focus 
on the main apprehensions of those targeted to enhance prostate screening.  
The ACS (2020) has published guideline recommendations for PCa screening, but 
AAs and other high-risk groups need more targeted education to address barriers. The 
ACS developed a PCa pamphlet and toolkit in 2019 consisting of an easy-to-read 
informational flyer translated in 12 different languages that included promotional 
activities to be used within any organization as well as short messages and helpful 
resources about PCa screening. Though informative, these resources need to be tailored 
for the AA population. The gap in practice that has been identified is a lack of 
educational resources for AA men about the benefits of PCa screening. Despite 
remarkable gains in overall life expectancy among other ethnic groups, life expectancy 
for AA men remains the same; specifically, life expectancy for Caucasian men is 74 
years and for AA men is 66 years (ACS, 2020). The disparity in life expectancy for AA 
men is disproportionate due to an excess in cancer incidences, so educating them on the 
importance of PCa screening to decrease the disparity is essential.  
Local Background and Context 
Although this project addressed no specific institution, the expert panelists came 
from my surrounding community and work-related peers. According to ACS (2020), 
41,000 American men die of PCa each year, with approximately 65% of this population 
consisting of AAs. The mortality rate from PCa among AA men is more than double that 
for Whites, with age-adjusted mortality rates of 64 per 100,000 and 26 per 100,000, 




southeastern United States, where deaths from PCa among AAs happen at nearly 3 times 
the national mortality rate for Whites. PCa screenings can provide earlier diagnoses, 
ultimately improving opportunities for successful treatment and decreasing mortality. The 
literature indicates that with preventive screening, AA men will be more aware of their 
prostate health and hence take more precautionary measures (ACS, 2020). AA men must 
be informed of the need to undergo screening and have fears and myths addressed.  
The myths and stigma associated with PCa among AAs are widespread. Likewise, 
the need for culturally based education is widespread; thus, this CPPEG will be 
appropriate for all providers who treat AA men. The evidence-based teaching guideline 
to educate AA men on PCa screening should, over time, decrease morbidity and mortality 
among the population through early diagnosis and treatment of the disease.  
Professional Organizations and Florida State Initiative Reviews 
  U.S. health organizations have declared that PCa screening, like other related 
cancer screenings, requires education and counseling so that patients are well-informed 
about the risks and benefits of screening and make informed decisions about their own 
healthcare. In 2018, the American Academy of Family Physicians issued updated clinical 
preventive service recommendations on PSA-based screening for PCa for AA men, based 
on examination of multiple evidence reviews by the U.S. Preventive Services Task Force 
to create its final statement of recommendation on PSA screening. Even with these new 
guidelines, screening rates among AA men remain low while the PCa prevalence among 




Caucasians (Tsodikov et al., 2017). Therefore, developing separate evidence-based 
guidelines for AA men should reduce the PCa burden among the AA population.  
The Florida PCa Advisory Council is a collaborative, multi-institutional, 
interdisciplinary advisory body that has established a communication platform between 
PCa stakeholders within the State of Florida by providing informational resources that 
validate and disseminate PCa information (Gupta et al., 2015). The Florida PCa Advisory 
Council’s mission is to make reliable information resources about PCa screening 
accessible to patients, advocates, physicians, care providers, researchers, and Florida’s 
governing officials about the need for prostate screening. The World Health Organization 
(WHO) promotes and emphasizes cancer prevention to improve quality of life. According 
to WHO, 30%-50% of cancer’s risk factors are due to unhealthy lifestyle practices such 
as poor nutrition, smoking, and lack of exercise. Men of African descent have the highest 
rate of PCa compared to all other ethnicities (Tsodikov et al., 2017). Therefore, educating 
the AA population about the importance of prostate screening and preventative measures 
can help in increasing screening rates and decreasing the disease among this vulnerable 
group. This PCa in AA Men project provided educational resources for AA men about 
the methods and benefits of PCa screening along with facts about the disease, thus 
dispelling myths, addressing fears, and closing the gap in practice.  
Role of the DNP Student 
My professional context with PCa derived from my years of experience working 
on an oncology floor. In this DNP PCa in AA Men project, I functioned as the leader. 




as guides, I developed an evidence-based CPPEG using current, evidence-based sources 
obtained through an exhaustive literature review. I selected a group of content experts 
who reviewed the newly developed CPPEG using the AGREE II tool. No revisions were 
needed, or recommendations were made, and the newly developed CPPEG was sent to 
the end users (providers in the community who care for AA males) to assess for content 
and useability; they agreed that the newly developed guideline was pertinent, well 
written, and all-inclusive and would be easy to use.  
My motivation for this project came from my father, who had PCa and died 2 
years ago from the disease. With increased knowledge, my father might have been 
screened and sought treatment earlier, resulting in a better outcome. I understand that I 
may be biased as to the content that is included in the CPPEG, based on my personal 
experience; however, I have minimized my biases by developing the CPPEG in concert 
with the current evidence-based literature and information from organizational sites, 
avoiding my personal opinion.  
Summary 
With statistics showing increased deaths and lack of prostate screening among 
AA men compared to their counterparts, a separate educational evidence-based guideline 
was needed to address cultural myths and barriers that deter this vulnerable group from 
receiving prostate screening, thus decreasing the disparity. My DNP PCa in AA Men 
project has provided providers with culturally sensitive, evidence-based guidelines to 
educate AA men and increase their awareness of PCa screening for more extended life 




developed from an extensive evidence-based literature search. In Section 3, I discuss the 





Section 3: Collection and Analysis of Evidence 
The burden of cancer affects all populations across the world. AA men are a 
minority community in the United States, and unwittingly they have more reported cases 
of PCa than their peers; research shows that AA men are 1.6 times more likely to have a 
positive PCa diagnosis and twice as likely to die from it (Bowen, 2018). Factors such as 
lack of screening, nutrition, sedentary lifestyle, family history, and race (Shenoy et al., 
2016) play a role in causing the disparity. There are many contributing factors, but 
prostate screening is recommended as a preventive measure to ensure early detection and 
treatment. 
The problem identified for this DNP PCa in AA Men project was the lack of 
screening among AA men despite the availability of such. I have developed a CPPEG to 
assist providers in educating AA men about the importance of PCa screening and 
addressing ethnic beliefs and barriers such as cultural and socioeconomic factors and 
poor healthcare access. Educational programs geared toward practitioners have been 
shown to be effective in bringing awareness of the risk for PCa and the benefits of 
screening. In this section, I discuss the practice-focused questions, the sources of 
evidence, and a relationship between the evidence and the purpose. The collection and 
analysis of evidence used to address the practice problem are described. 
Practice-Focused Questions 
The issue that I addressed in this evidence-based DNP PCa in AA Men project 
was a lack awareness of the importance of or need for PCa screening in AA men despite 




educational resources for practitioners to use when educating AA men about the benefits 
of PCa screening. Lack of educational resources creates a concern because AA men have 
limited knowledge and skewed perceptions of PCa screening in addition to negative 
attitudes toward annual routine checkups (Hahn et al., 2015). Therefore, developing 
culturally specific evidence-based guidelines for AA men should help to increase PCa 
screening. Hence, the practice-focused questions that guided this PCa in AA Men project 
were as follows: What evidence from the literature supports the need for patient 
education related to PCa screening in AA men? Can a CPPEG be developed and 
validated to guide nurses in educating AA men on the importance for PCa screening? The 
purpose of the project was to develop an evidence-based CPPEG to assist providers when 
educating AA men on the benefits of PCa and the risks and management of PCa so that 
they are better prepared to make informed decisions in their care.  
Sources of Evidence 
The CPPEG was based on evidence from current, peer-reviewed, published 
research discovered in an in-depth literature search of peer-reviewed articles published 
within the last 5 years unless they were landmark studies. Guidelines from professional 
organizations and the Florida Advisory Council were also incorporated. The literature 
was organized in a literature matrix (see Appendix A) and graded using the hierarchy of 
evidence from Fineout-Overholt et al. (2010; see Appendix B) with articles from all 
except Level 2 (individual single random control trials) of the seven levels.  
This evidence from the literature and recommendations from professional 




with current, evidence-based tools to educate AA men on the pros and cons of PCa 
screening. Including higher levels of literature to include systematic reviews of 
randomized controlled trials added strength to the guideline. An additional source of 
evidence collected through this project was the results of the AGREE II tool provided by 
the content experts, which established the quality of the newly developed CPPEG, along 
with feedback from the end users, the nurses, and the providers, who agreed that the tool 
would be useful to teach AA men about the importance of PCa screening.  
Evidence Generated for the Doctoral Project 
Participants  
Following recommendations of the AGREE II tool (AGREE Enterprise, n.d.), 
each guideline was assessed by four appraisers, as this increased the reliability of the 
assessment; the expert panel consisted of an oncology nurse educator, a nurse 
practitioner, an oncologist, and an oncology nurse with their MSN. These members were 
selected for their expertise in PCa, their knowledge in evidence-based guidelines, and the 
fact that they could relate to the practice-focused questions because of the low numbers in 
screening in the target population seen in their practices. In addition, their direct 
interaction with this population was a plus. The end users, three providers from the 
community, reviewed the guideline for content and usability.  
Procedure 
After an extensive literature search, I arranged the pertinent articles in a literature 
matrix and graded the evidence using criteria from Fineout-Overholt (2010). From this 




Appendix E) and mailed a packet consisting of an introductory letter, the CPPEG, the 
literature matrix, a disclosure form, the AGREE II tool, the AGREE II tool scoring sheet 
(see Appendix D), and a link to the AGREE site to the expert panelists. The expert panel 
was asked to review the quality of the CPPEG using the AGREE II tool 
(www.agreetrust.org) and provide feedback within 2 weeks. The expert panelists 
reviewed the CPPEG, with no revisions requested or recommendations provided. The 
CPPEG was then presented to four end users (providers and nurses) who were asked to 
review it and provide feedback on content and usability. I developed a final report and 
shared it with the expert panel. After graduation, I will share the newly developed CPG 
with administrators in the surrounding area for consideration of adoption, at which time I 
will present the CPPEG to the providers; for wider dissemination, I will present at local, 
regional, and national organizations’ conferences, state board meetings, and community 
clinics.  
Protections 
Approval from Walden University’s Institutional Review Board and the facility 
were obtained after the proposal was accepted. No identifying information was collected 
on the AGREE II website, ensuring that the reviews were anonymous. There were no 
paper files as the evaluations were completed on the AGREE site. All electronic files will 
be maintained on a password-protected computer that only I will have access to for 5 




Analysis and Synthesis 
The AGREE website (www.agreetrust.org) was used for recording, tracking, 
organizing, and analyzing the evidence. The panelists were instructed to enter their scores 
through the website. The website analyzed the findings and developed a final report, 
which was sent to me. I reviewed the findings; all scores were above the benchmark of 
75%, and no recommendations were made, nor revisions needed. From the findings, I 
developed a final report. As the AGREE website gathers no identifying data, all 
responses were anonymous. Reviewing the end users’ comments, I included their 
responses in the final report. Summary evaluations from the content experts were also 
reviewed, providing me with an evaluation of the process, the project, and my leadership 
throughout the process.  
Summary 
In summary, AA men are a minority community in the United States but have 
more reported cases of PCa compared to other cultures. The factors linked to the higher 
PCa incidence include nutrition, lack of screening, family history, race, and sedentary 
lifestyle. Educational programs geared toward educating men on the importance of 
having PCa screening can minimize PCa cases among AA men, but AA men are reluctant 
to be screened. In this DNP PCa in AA Men project, I developed a CPPEG to guide 
nurses and other providers in addressing the lack of PCa screening among AA men based 
on peer-reviewed, published research from Walden Library. An expert panel used the 
AGREE II tool to evaluate the CPPEG; no recommendations were made, and no 




developed CPPEG for content and useability, receiving positive feedback from them. In 





Section 4: Findings and Recommendations 
The local problem identified for this DNP PCa in AA Men project was the lack of 
screening among AA men despite the availability of such. The goal of PCa screening is to 
reduce death among AA men. The gap in practice was the lack of educational resources 
for AA men about the benefits of PCa screening. The practice-focused questions that 
drove the project were the following: What evidence from the literature supports the need 
for patient education related to PCa screening in AA men? Can a CPPEG be developed 
and validated to guide nurses in educating AA men on the importance of PCa screening? 
The purpose of the project was to develop an evidence-based CPPEG to guide 
practitioners when educating AA men about the significance of PCa screening so that 
they can make an informed decision about their care. The sources of evidence that were 
used to develop this CPPEG were peer-reviewed articles found in the Walden library and 
through professional organizations. The AGREE II instrument was used by the expert 
panel to evaluate the newly developed CPPEG for rigor and clarity. The end users 
evaluated the newly developed guidelines for content and usability, and the content 
experts provided feedback on the process, the project, and my leadership through a 
summary evaluation. In this section, I will discuss the findings and the implications, 
recommendations, and strengths and limitations of the project.  
Findings and Implications 
After an in-depth review of the literature, a literature matrix was developed (see 
Appendix A) by using pertinent articles that were graded using Melynk grading criteria. 




7articles were selected for use in the development of the CPG. The vast number of peer 
reviewed articles and numerous systematic reviews added strength to the CPPEG. 
Four expert panelists provided evaluations of the newly developed CPPEG on the 
AGREE II website. The evaluations addressed the 23 items from the six domains, with 
scores for each domain above 75%. The threshold for high quality is scores above 50% 
for each domain; however, any scores below 75% should be evaluated (AGREE 
Enterprise, n.d.). Domain 1, scope and purpose scored 100%; Domain 2, stakeholder 
involvement, scored 93%; Domain 3, rigour of development, scored 92%; Domain 4, 
clarity of presentation, scored 100%; Domain 5, applicability, scored 90%; Domain 6, 
editorial independence, scored 92%; and the overall appraisal score was 96% (see 
Appendix D).  
The reviewers only scored individuals from all the relevant professional groups 
being included in the development of the CPG at 24/28; the variety in education and roles 
of the reviewers addressed this requirement. Also questioned was the monitoring and/or 
auditing criteria, which were clearly addressed at the end of the introduction with the 
statement “the guideline should be reevaluated every 3 years or when new 
recommendations for prostate screening in AAM are published.” Auditing is addressed in 
the recommendations and evaluation of the project. One panelist commented that PCa in 
AA men is a health issue that needs addressing with educational interventions, while 
another appraiser commented that there is a demonstrated need for education and 




Two of the end users who were providers and nurses commented that the CPG 
was well developed, clear, and concise and that it is a tool that is user friendly and likely 
to make a change in how AAs are educated, addressing cultural issues and concerns and 
making them more knowledgeable about PCa screening, ideally improving quality of life 
for AAs. Both the expert panelists and end users had never seen a CPG specific to AA 
men and PCa screening, supporting the need for the project. The CPPEG is an evidence-
based educational tool to guide providers in teaching AA men and better preparing them 
to make an informed decision about their care, fostering positive social change by 
increasing PCa screening in this vulnerable group.  
Recommendations  
The gap in practice for this DNP project was the lack of educational resources for 
AA men about the benefits of PCa screening. That gap was addressed by developing a 
culturally sensitive, evidence-based guideline for providers to use for educating AA men 
with appropriate knowledge to better equip them in making decisions regarding their care 
based on knowledge gained through the education that they received on the importance of 
prostate screening. There was no specific site for the project, but there are several sites 
that I intend to share the guideline with after graduation; I will present the CPG to 
administrators at doctors’ offices and community clinics for consideration of 
implementation and then present the information to the nurses and providers. My desire is 




Strengths and Limitations of the Project  
 The focus of this DNP project was to fill the gap in practice, which was the lack 
of educational resources for AA men about the benefits of PCa screening, by providing 
nurses and providers with a culturally sensitive guide tailored to AA men. The end 
product provides a ready resource of appropriate information needed to aid AA men in 
making informed decisions regarding their care. One of the strengths of the newly 
developed CPPEG was the amount of culturally relevant, evidence-based resources 
available to be included in the newly developed guideline. The positive feedback 
received from the expert panelists and their willingness to use this tool was another 
strength. One of the appraisers commented that there is a demonstrated need for 
education and culturally based care for AA men.  
 One of the limitations for this DNP project was that there was no set organization 
affiliated with it due to the pandemic and associated restrictions; this will delay my 
dissemination until the pandemic restrictions are lifted. Visiting these multiple sites is the 
only way to have the newly developed CPPEG implemented. Another limitation was my 
time constraints, as I am currently paying for this terminal degree out of pocket and I am 
financially strained. In addition to financial obligations, family commitments have been 
neglected due to work overload and sleepless nights to complete this terminal degree.  
The review of the available literature provided me with valuable knowledge that I 
will use throughout my career. I feel better prepared to be a spokesperson for the 
prevention and early diagnosis of PCa, especially in AA men. I am also more aware of 




These barriers, myths, and fears are all areas that I hope to address in future projects. 
After my newly developed CPPEG is implemented, I will lead the facilities in evaluating 
the implementation, comparing screening rates, and, over time, reducing the incidence of 
PCa in the AA population. Seeing positive changes should further support the validity of 
the CPPEG.  
Summary 
The findings and implications for this project were centered around the expert 
panelists’ evaluation using the AGREE II instrument. The panelists favored the CPPEG 
and gave high scores in all six domains (see Appendix D). Their feedback on the need for 
this culturally based educational intervention was paramount. The strength of this project 
was that the gap in practice was addressed, and the differences between ethnicities in PCa 
screening should be minimized due to providing a culturally sensitive, evidence-based 
teaching tool to address the fears, myths, and misinformation that have been found to add 
to the disparity for AA men regarding PCa. In Section 5, I will focus on my self-analysis 
and summary of the final DNP project, including challenges, solutions, and insights 





Section 5: Dissemination 
The implementation of this project will extend after graduation when I can present 
the CPPEG to various organizations. I will share the newly developed CPPEG in doctors’ 
offices and community clinics where patients are often seen for their yearly or routine 
visits. Urology and oncology clinics are other settings that I will approach, as they are the 
referral sites for the population that this CPPEG will benefit. I plan to meet with 
administrators and present my newly developed CPPEG to get authorization to offer it to 
nurses and providers. I will highlight critical information to strengthen screening and 
embrace a proactive approach toward PCa among AA men. Using a collaborative 
approach to dispel myths and misconceptions surrounding PCa screening is vital (Shenoy 
et al., 2016). PCa is widespread, and its occurrence is increasing among AA men.  
Although providing the newly developed CPPEG in the surrounding community 
will impact the local population, it is through publication and presentations at regional, 
national, and global professional meetings that I will make the biggest impact. Therefore, 
I will query pertinent journals, to include Clinical Journal of Oncology Nursing and 
The Journal of the National Black Nurses Association, for consideration for publication 
and submit an abstract to present the project at The Cancer Nursing conference.  
Analysis of Self 
I started my nursing career as a registered nurse on an oncology unit; I remember 
saying to myself, “oh no, oncology,” but later it became a passion for me, especially after 
my dad got diagnosed with and died from PCa. I found my passion for educating and 




degree and then my terminal degree. I developed this CPPEG so that I can bring 
awareness of and provide resources on the importance of prostate screening, especially to 
AA men, by educating providers on how to educate AA men to make informed decisions 
about their care.  
Practitioner 
As a DNP student carrying out this project, I was able to take on roles as 
practitioner, scholar, and project manager. In the role of practitioner, I was able to use my 
educational background and clinical expertise to review evidence-based practice 
guidelines, identify the problem that the project was focused on, and develop a CPPEG 
that nurses and providers will use to enhance the education provided to AA men. In this 
role, I found that this was one of the ways that a DNP-prepared nurse fosters the bridging 
of the gap of research and practice. As a practitioner, one of my strengths was my ability 
to research the literature and find meaningful articles for this project; however, one of my 
weaknesses was accurately applying the appropriate grade level to each article in relation 
to the literature matrix, which required me to seek assistance from the Walden Library 
and my peers. To minimize this weakness, I spent time deciphering the actual grading 
tool for similarities between grading Level 1 and Level 7 articles.  
Cultural differences do affect health beliefs and patient education; therefore, 
addressing these disparities will positively impact outcomes and enhance learning in the 
target population. My long-term goal is to find a full-time academic position in the 




educational interventions and educating the AA male population about the need for PCa 
screening. 
Scholar 
The road to my DNP has been filled with great experiences—experiences of both 
joy and sadness as my father passed away from PCa before I could complete this terminal 
degree. As a scholar, I focused on my courses and learning everything possible. In 
reflecting on my journey, I have learned to look at what it takes to be a scholar in a 
different light, such as the ability to research and break down the elements into usable 
components that nurses can use to improve nursing care. I was able to identify and 
overcome many challenges (personal and professional), which I had to navigate 
sometimes single-handedly, to be able to be at this juncture. The education obtained has 
solidified the many aspects of integrating changes within the nursing sector that will align 
with current healthcare legislation recommendations as it pertains to evidence-based 
research. In my professional career, I have advanced by sitting on committees to 
implement changes to patient care aligned with evidence-based practice through research. 
Additionally, I have aided in implementing patient safety policies through data analyses 
to identify patient safety issues using evidence-based interventions, demonstrating that a 
new approach will lead to improved quality and patient safety. My long-term professional 
goal is to find an adjunct faculty position teaching online and continue working as an 





Being a project manager was stressful, as I did not know anything about the 
AGREE II website. I was fortunate that three of my expert panelists were familiar with 
the website, but I had to be familiar with the site so that I could aid the other expert 
panelist. This was a tedious, even stressful, task for me. As it was my first time 
encountering the AGREE II website, I had to reach out to my peers for guidance on how 
to navigate the site. However, the end product, the newly developed CPPEG for nurses 
and providers, gave me a sense of fulfillment, knowing that providers would now have 
access to an evidence-based guideline specific to AA men for teaching them about PCa 
screening and addressing culturally sensitive barriers.  
Challenges, Solutions, Insights Gained 
  The challenges that I faced during this process were personal and academic. 
Completing some of the core courses was extremely challenging for me, as some courses 
lacked clarity and I had to keep reaching out to the professor for assistance; sometimes, 
the clarification took 2 to 3 business days or even longer, which increased my anxiety 
even more. I was not aware that while working on the core courses I could have initiated 
the proposal. While working on my project, my father passed away from PCa, which led 
me to take a semester off. However, the greatest challenges that I faced were the 
revisions of this scholarly project; another challenge was learning how to navigate the 
AGREE website to aid the panelists who had no knowledge of the site.  
I have gained new insights on the importance of seeking early guidance—for 




revision, which would have fostered a quicker completion of my DNP project. Other 
personal obligations, including taking care of family responsibilities and working while 
trying to complete school, were very demanding. The biggest academic challenges that I 
faced were making the necessary revisions and doing the literature matrix. In addition, 
trying to understand the AGREE II tool was not an easy task to accomplish. The 
completion of this project has provided me the opportunity to gain further insights about 
myself and the profession of nursing. I have a better understanding of the importance of 
the DNP role as it relates to converting evidence-based information into evidence-based 
practice. Finally, through this role, I can make a difference in the lives of patients, nurses, 
and providers, ensuring that clinical practices are based on scientific methodologies.  
Summary 
 PCa is significant disease that impacts men globally, but with an excellent 
survival rate when it is detected early. AA men are 50% more likely to develop and die 
from PCa compared to men of another ethnicity. They have the lowest rate of prostate 
screening when screening is readily available. The purpose of this doctoral project was to 
develop a CPPEG for nurses and providers to use to educate AA men on the importance 
of prostate screening. The supporting literature supported the need for nurses to know the 
significance of culturally related barriers that AA men have related to PCa. The 
implementation of the newly developed CPPEG will fill the gap of not having a 
standardized, culturally sensitive educational teaching tool. Working through endless 
challenges of writing the guideline and having an appraisal completed by a diverse panel 




afforded me the latitude of providing other healthcare practitioners a CPPEG that is 
grounded in scientific underpinnings. Culturally sensitive education will always be 
imperative, and it is one of my responsibilities, as an advanced nurse practitioner, to 
assist nurses and clients in promoting and enhancing quality individual care. Finally, the 
evaluations from the expert panelists reinforced that this newly developed evidence-based 
CPPEG should positively impact nurses’ and patients’ knowledge when it comes to 
educating and performing self-care practices toward self-screening for PCa, decreasing 
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Note. Evidence graded using the hierarchy of evidence model from “Evidence-based Practice Step by Step: 
Critical appraisal of the evidence: Part I,” by  E. Fineout-Overholt , B. M. Melnyk, S. B Stillwell, and K. M 






Appendix B: Melynk and Fineout’s (2011) Levels of Evidence  
 





Appendix C: AGREE II Instrument 
Domain 1. Scope and Purpose 
1. The overall objective(s) of the guideline is (are) specifically described. 
2. The health question(s) covered by the guideline is (are) specifically described. 
3. The population (patients, public, etc.) to whom the guideline is meant to apply 
is specifically described. 
Domain 2. Stakeholder Involvement 
4. The guideline development group includes individuals from all the relevant 
professional groups. 
5. The views and preferences of the target population (patients, public, etc.) have 
been sought. 
6. The target users of the guideline are clearly defined. 
Domain 3. Rigor of Development 
7. Systematic methods were used to search for evidence. 
8. The criteria for selecting the evidence are clearly described. 
9. The strengths and limitations of the body of evidence are clearly described. 
10. The methods for formulating the recommendations are clearly described. 
11. The health benefits, side effects, and risks have been considered in 
formulating the recommendations. 
12. There is an explicit link between the recommendations and the supporting 
evidence. 




14. A procedure for updating the guideline is provided. 
Domain 4. Clarity of Presentation 
15. The recommendations are specific and unambiguous. 
16. The different options for management of the condition or health issue are 
clearly presented. 
17. Key recommendations are easily identifiable. 
Domain 5. Applicability 
18. The guideline describes facilitators and barriers to its application. 
20. The guideline provides advice or tools on how the recommendations can be 
put into practice. 
21. The potential resource implications of applying the recommendations have 
been considered. 
22. The guideline presents monitoring or auditing criteria. 
Domain 6. Editorial Independence 
23. The views of the funding body have not influenced the content of the 
guideline. 
24. Competing interests of guideline development group members have been 






Appendix D: AGREE II Scores  
 
 
A critical group appraisal of: 
Clinical Practice Guideline 
using the AGREE II Instrument 
Created with the AGREE II Online Guideline Appraisal Tool. 
No endorsement of the content of this document by the AGREE Research Trust 
should be implied. 
Co-ordinator: Joain Silvera 
Date: 30 July 2021 
Email: joain.silvera@waldenu.edu 





















100% 93% 92% 100% 90% 92% 96% 
Yes - 4, Yes with 
modifications - 0, 
No - 0 
 
Domain 1. Scope and Purpose 
  Appraiser 3 Appraiser 1 Appraiser 2 Appraiser 4 
Item 1 7 7 7 7 
Item 2 7 7 7 7 
Item 3 7 7 7 7 
  
Domain 2. Stakeholder Involvement 
  Appraiser 3 Appraiser 1 Appraiser 2 Appraiser 4 
Item 4 6 6 7 5 
Item 5 6 7 7 7 
Item 6 7 7 7 7 
  
Domain 3. Rigour of Development 
  Appraiser 3 Appraiser 1 Appraiser 2 Appraiser 4 
Item 7 6 7 7 6 
Item 8 7 7 6 7 
Item 9 6 6 7 5 
Item 10 7 7 7 6 
Item 11 7 7 7 7 




Item 13 6 6 6 7 
Item 14 6 6 7 7 
  
Domain 4. Clarity of Presentation 
  Appraiser 3 Appraiser 1 Appraiser 2 Appraiser 4 
Item 15 7 7 7 7 
Item 16 7 7 7 7 
Item 17 7 7 7 7 
  
Domain 5. Applicability 
  Appraiser 3 Appraiser 1 Appraiser 2 Appraiser 4 
Item 18 6 6 6 7 
Item 19 7 6 7 7 
Item 20 7 7 7 6 
Item 21 5 5 6 7 
  
Domain 6. Editorial Independence 
  Appraiser 3 Appraiser 1 Appraiser 2 Appraiser 4 
Item 22 7 6 6 7 
Item 23 7 7 6 6 
  
Overall Assessment 
  Appraiser 3 Appraiser 1 Appraiser 2 Appraiser 4 
OA1 7 7 6 7 
 
 




(a) Domain 1. Scope and Purpose 
Item 1 
• Appraiser 3: Yes, the CPG was described in detail 
• Appraiser 4: Very well presented. 
Item 2 
• Appraiser 3: Yes, the question described the issue at hand 
• Appraiser 4: Presented by candidate. 
Item 3 
• Appraiser 3: Yes, African American men population 
• Appraiser 4: The population is identified, and description is noted. 
 
(a) Domain 2. Stakeholder Involvement 
Item 5 
• Appraiser 4: Clearly identified. 
Item 6 
• Appraiser 3: Yes, nurses and providers 
 
(b) Domain 3. Rigour of Development 
Item 8 
• Appraiser 3: Yes, the evidence selecting African American men disparity 
to prostate cancer was clear and concise 
Item 9 




(a) Domain 4. Clarity of Presentation 
Item 15 
• Appraiser 4: Clearly defined 
Item 16 
• Appraiser 4: Well, presented. 
(b) Domain 5. Applicability 
Item 18 
• Appraiser 4: Noted 
Item 19 
• Appraiser 4: Recommendations noted 
 
c) Domain 6. Editorial Independence 
No comments found for this domain. 
 
(c) Overall Assessment 
• Appraiser 3: Prostate cancer in African American men is a health issue 
that needs addressing with educational intervention. 
• Appraiser 4: There is a demonstrated need for education and culturally 
based care for the African American community. This guide minority-
based health disparities. 
 
 





Appendix E: Teaching Guidelines for Screening Prostate Cancer  
in African American Men (AAM) 
Purpose: 
 To provide teaching guidelines to assist providers in educating AAM on the 
importance of prostate cancer screening. This CPG will address the need for 
comprehensive, culturally based education guidelines for providers to share with 
AAM aged 40 and older to change their perceptions, with the intention of 
increasing prostate screening among AAM.   
 
Procedure: 
• Education will start at the doctor’s office  
o nurses will communicate the importance of prostate cancer screening at 
the male’s annual well checkups. 
• The nurse will: 
o explain what prostate cancer is 
o discuss signs and symptoms of prostate cancer  
▪ explain how prostate cancer can be asymptomatic at times so 
screening is essential  
▪ discuss the potential risks of prostate cancer  
▪ explain the benefits of prostate cancer screening 
▪ discuss the meaning of a PSA test  
▪ explain what a digital exam is  
▪ Allow for discussion are questions related to the procedure 
▪ Answer questions and clarify questions as needed  
• The nurse will review information at every visit  
 
Question: 
What information specific to AAs do providers need to educate AAM, potentially 
increasing screening and decreasing the disparity of morbidity and mortality from 









Prostate cancer is a significant health issue for AAM. It is essential to adequately 
plan and implement educational interventions that target behaviors through 




• Because AAM are more vulnerable and reluctant to be screened  
• Wardle et al. (2015) explained that providing clinicians with education 
was an effective means to optimize screening among individuals at risk for 
cancer. 
• Educational programs geared towards practitioners were identified as 
effective in increasing the patients’ awareness of the risk for prostate 
cancer and the benefits of routine screening (Rice et al., 2017).  
• Screening as a preventive measure is recommended early and regularly to 
ensure that early detection leads to effective treatment and recovery 
(Tsodikov et al., 2017).  
• Routine screening has been touted to be the most effective strategy for 




The American Cancer Society (ACS, 2019) estimated more than 202,000 men have 
prostate cancer of which over 73,000 are expected to die from the disease.  
• In 2019 an estimated 30,000 cases of prostate cancer were diagnosed in AAM. 
• Prostate cancer is disproportionately higher in AAM compared to other ethnic 
groups in the United States. Prostate cancer incidence is 60% higher in AAM 
than white men.  
• Mortality rate is double in AAM than white men.  
• The high incidence of prostate cancer in AAM has remained remarkably 
constant for more than 20 years (Tsodikov et al., 2017).  
o The reason for such disparity is unclear but probably due to 
socioeconomic factors such as race, family history, lack of education, 
and health insurance (Shenoy et al., 2016).  
• Culturally sensitive education has the potential to increase AAM participation 





• The guideline should be reevaluated every 3 years or when new recommendations 
for prostate cancer screening in AAM are published. 
• Barriers to the application of this guideline should be addressed as they arise by 
the providers and before application.  
 
 
This Prostate Cancer in AAM project did not request or receive any funding for the 





Teaching Guidelines for Screening Prostate Cancer in African American Men      
    
This guideline is intended to increase knowledge about prostate screening among African 
American men (AAM) 
 
What is Prostate Cancer? 
Prostate cancer is a type of tumor that occurs in the prostate, which is small 
walnut-like shaped gland in males that functions to produce seminal fluid that 
moves and nourishes sperms. The body part that is affected is the prostate gland. 
The prostate gland is a part of the male reproductive system, between the penis 
and the rectum, that secretes fluid to mix with semen during ejaculation.  
• Signs and symptoms of Prostate Cancer: 
▪ Early prostate cancer may show no symptoms, but some patients may 
experience   
▪ difficulty voiding 
▪ urinary retention  
▪ pain in the hip, back, or bones 
▪ constipation and/or blood in the urine or semen  
• Potential risk factor for prostate cancer:  
▪ Age- the risk of prostate cancer increases with age, especially over the age 
of 50 
▪ With family member having prostate cancer 
• begin screening at age 40 
▪ Race- Black men are diagnosed with prostate cancer more than men from 
other ethnicities                                                                                                                                                                        
▪ Start annual screening by age 50 
▪ Socioeconomic status 
▪ African American men are more likely to have a lower 
socioeconomic status than other men.  




▪ Low income  
▪ financial barriers are a major contributor to prostate 
cancer outcomes (Shenoy, et al, 2016).  
▪ provide easy access to providers 
▪ Lack of education 
▪ provide easy to understand materials  
▪ Cultural  
▪ Health practices, illness beliefs, and behaviors are motivated by Black 
men’s ideas about being macho or manly.  
• Generally, Black men are said to take pride in having and 
maintaining a high level of wellness without needing to 
consult a health care provider (Allen et al., 2007)  
• being ill threatens what it means to be a man  
o Racial bias in health care- 
• AAM may face racial bias in healthcare due to the color of 
their skin  
• Provider’s lack of understanding of how to converse 
with AAM  
▪ May avert treatment  
▪ Less likely to be told about prostate 
screening and prostate specific antigen test 
(PSA) in preventive care compared to their 
White counterparts.  
▪ Family History 
• Having a relative with prostate cancer increases the risk of 




• There is nothing to do to prevent it, but early 
detection could save one’s life  
▪ Talk to each patient about when to start 
screening, based on their individual history 
▪ All AAs, by the age of 50 
▪ At least by the age of 40, with one family 
member having prostate cancer 
 
How is prostate cancer screening done? 
• PSA is a blood test which measures the amount of protein cells in the 
body 
o The body produces normal protein cells, as well as cancerous ones 
which causes prostate cancer 
o PSA levels of 4.0 ng/mL and lower are considered normal  
▪  a PSA level above 4.0 ng/mL is considered abnormal  
• doctors would often recommend a 
prostate biopsy to determine if prostate cancer is 
present 
o any inflammation or irritation of the prostate 
can also cause an elevation 
• Digital exam 
o providers insert a lubricated finger in the rectum to check for 
swelling and inflammation  
▪ this is uncomfortable and could be embarrassing, but is 
necessary 
• The results would indicate an enlarged prostate, 
abscesses, or rectal cancers  
• If abnormality is found the provider would indicate 




o a small probe inserted in the rectum to take a 
picture of the prostate gland 
• A prostate biopsy will also be done  
o a thin needle is inserted into the prostate to 
collect tissue. The tissue sample is examined 
in a lab to determine if cancer cells are 
present 
What are the benefits of prostate screening?  
• Screening for prostate cancers will help reduce the spreading of the cancer  
▪ treatment before it spreads may lower the chance of death from prostate 
cancer in some men 
▪ Given the high risk of developing and dying from prostate cancer, AAM 
are more likely to be saved by screening.  
 
• Screening consists of:  
▪ a prostate specific antigen test (PSA)  
▪ a blood test which measures the level of PSA in the blood. 
• digital rectal exam  
▪ provider will insert a well lubricated finger in the rectum to check for 









PROSTATE CANCER SCREENING 
Patient Education for the AA Male 
 
What is Prostate Cancer? 
Prostate cancer is a type of tumor that occurs in the prostate gland, which is a 
small walnut-like shaped gland in males that functions to produce seminal fluid to 
nourish and move sperm. The body part that is affected is the prostate gland. The 
prostate gland is a part of the male reproductive system, between the penis and the 
rectum, that secretes fluid to mix with semen during ejaculation.  
• Signs and symptoms of Prostate Cancer: 
▪ Early prostate cancer may show no symptoms, but some patients may 
experience  
▪ difficulty urinating (passing water) 
▪ urinary retention (unable to pass urine) 
▪ pain in the hip, back, or bones 
▪ constipation and/or blood in the urine or semen  
• Potential risk factor for prostate cancer:  
▪ Age- the risk of prostate cancer increases with age, especially over the age 
of 50 
▪ Begin prostate screening by age 50 
▪ With family member having prostate cancer 
• begin screening at age 40 
▪ Race- Black men are diagnosed with prostate cancer more than men from 
other  
           groups 
▪ Start annual screening by age 50, 40 if you have a family history 
▪ Socioeconomic status 
▪ Do you need help paying for your medicines? 
• YES – see APPENDAGE A 
▪ Do you have insurance? 
• YES – see APPENDAGE B 
▪ Cultural  
▪ Health practices, illness beliefs, and behaviors are motivated by 




▪ Access to healthcare  
▪ Trouble finding a provider? 
▪ Provider too far away?  
 
• See APPENDAGE C 
▪ Lack of transportation to provider?  
• See APPENDAGE D 
▪ Promote good health practices, at an early age that will promote 
AAM to seek early medical attention  
• See APPENDAGE E 
How is prostate cancer screening done? 
• PSA (prostate screening antigen) is a blood test that measures the 
amount of a specific protein cells in your body produced by the body 
o These can be normal cells or cancerous ones which cause prostate 
cancer 
o PSA levels of 4.0 ng/mL and lower are considered normal  
▪  a PSA level above 4.0 ng/mL is considered abnormal  
o any inflammation or irritation of the prostate 
can also cause an elevation 
• doctors would often recommend a 
prostate biopsy to determine if prostate cancer is 
present 
• Digital exam 
o Provider will insert a lubricated finger in the rectum to check for 
swelling and inflammation  
▪ this is uncomfortable and could be embarrassing, but is 
necessary 
• The results would indicate an enlarged prostate, 
abscesses, or rectal cancers  
• If abnormality is found the provider would indicate 
further testing such as an ultrasound  
o a small probe inserted in the rectum to take a 
picture of the prostate gland 
• A prostate biopsy will be done  
o a thin needle is inserted into the prostate to 




in a lab to determine if cancer cells are 
present 
What are the benefits of prostate screening?  
• Screening for prostate cancers will help reduce the spreading of the cancer  
▪ treatment before it spreads may lower the chance of death from prostate 
cancer in some men 
▪ Given the high risk of developing and dying from prostate cancer, AAM 
are more likely to be saved by screening.  
 
Patient Signature _____________________________________Date________ 
 









If you need help paying for their medication:  
• call your provider’s office to see if they have any medication 
samples available  
• call your pharmacy to see if you are qualified for any patient 
assistance program  
o patients who meet certain criteria can receive their 
medications for free or up to 80% paid for them 
• Contact the drug manufacturer (contact information often available 
on the medicine bottle or on the internet) 
o They often have financial assistance available for those 









No insurance?  
• Talk to the case manager 
o They may be able to help you find an affordable program 
you qualify for 
o They may be able to assist with paperwork 
• Call Medicaid 






Access to Providers 
 
Trouble finding a provider?  
 
• Free community clinics: 
o  Jackson Health System 305 585 xxxx 
o Citrus Health System   305- 825 xxxx 
o Jessie Trice Health System 305 637 xxxx 
o Community Health of South Florida 786 293 xxxx 
▪ These clinics provide assistance to patients with and 
without insurance to obtain screening and also 








Lack of transportation to providers? 
• Call your clinic 
o some of the clinics provide free transportation, picking you 
up at your home and bringing you to the clinic 
• Ask your provider’s office about telehealth 
o Telehealth services are often available if you have access to 
a phone or a computer  









Begin good health practices that promote seeking early medical attention NOW: 
 
• includes healthy lifestyle, such as 
o not smoking  
▪ need help quitting? 
• ask your provider, help is available 
o reduce alcohol drinking  
▪ need help? 
• AA is free and available, ask your provider for 
information  
• your minister often can provide resources  
o reduce fatty foods  
▪ a nutritionist is usually available through your provider 
• ask for a referral  
o eat more fruits and vegetables  
▪ a nutritionist is usually available through your provider 
▪ does your community have a “free garden” ? 
▪ do you qualify for grocery assistance? 
• ask for a referral 




▪ exercise can reduce infection, improve immune function 
and fight some of the negative health effects   
• many insurances cover gym membership or exercise 
classes 
• You tube and Google have many free exercise tapes 
o ask your provider for suggestions  
 
